Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates
Open Access
- 22 May 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Infectious Diseases and Therapy
- Vol. 4 (2), 187-198
- https://doi.org/10.1007/s40121-015-0067-9
Abstract
Introduction The pharmacokinetics of vancomycin are highly variable among neonates, which makes dosing challenging in this population. However, adequate drug exposure is critical, especially when treating methicillin-resistant Staphylococcus aureus (MRSA) infections. Utilization of population pharmacokinetic models and Bayesian methods offers the potential for developing individualized therapeutic approaches. To meet this need, a neonatal vancomycin population pharmacokinetic model was recently published. The current study sought to externally evaluate the predictive performance and generalizability of this model. Methods A retrospective chart review of neonates who received vancomycin and had ≥1 peak and ≥1 trough concentrations at five Intermountain Healthcare neonatal intensive care units from 2006 to 2013 was performed and served as the external validation cohort. The published population pharmacokinetic model was implemented in NONMEM 7.2 with the structural and variance parameter values set equal to the estimates reported previously. The model was then used to predict the first peak and trough concentration for each neonate in the validation cohort and the model prediction error and absolute prediction error were calculated. Normalized prediction distribution errors (NPDE) were also evaluated. Results A total of 243 neonates were studied with a median postmenstrual age of 33 (range: 23–54) weeks and a median weight of 1.6 (range: 0.4–6.8) kg. The model predicted the observed vancomycin concentrations with reasonable precision. For all vancomycin concentrations, the median prediction error was −0.8 (95% CI: −1.4 to −0.4) mg/L and the median absolute prediction error was 3.0 (95% CI: 2.7–3.5) mg/L. No trends in NPDE across weight, postmenstrual age, serum creatinine, or time after dose were observed. Conclusion An evaluation of a recently published neonatal vancomycin population pharmacokinetic model in a large external dataset supported the predictive performance and generalizability of the model. This model may be useful in evaluating neonatal vancomycin dosing regimens and estimating the extent of drug exposure.Keywords
Funding Information
- American Foundation for Pharmaceutical Education
- National Institute of Child Health and Human Development (1K23HD079557)
This publication has 20 references indexed in Scilit:
- Association between Vancomycin Trough Concentration and Area under the Concentration-Time Curve in NeonatesAntimicrobial Agents and Chemotherapy, 2014
- Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infectionsExpert Review of Anti-infective Therapy, 2014
- Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?Antimicrobial Agents and Chemotherapy, 2014
- Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administrationSeminars in Fetal and Neonatal Medicine, 2013
- Vancomycin Dosing: Assessment of Time to Therapeutic Concentration and Predictive Accuracy of Pharmacokinetic Modeling SoftwareAnnals of Pharmacotherapy, 2011
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and ChildrenClinical Infectious Diseases, 2011
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- Impact of Standardization of Creatinine Methodology on the Assessment of Glomerular Filtration Rate in ChildrenPediatric Research, 2009
- Bayesian approaches in pharmacokinetic decision making.1984
- Bayesian Individualization of Pharmacokinetics: Simple Implementation and Comparison with Non-Bayesian MethodsJournal of Pharmaceutical Sciences, 1982